Structure

InChI Key KPWSJANDNDDRMB-QAQDUYKDSA-N
Smile CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
InChI
InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)/t16-,17-

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H32Cl2N4O
Molecular Weight 427.42
AlogP 4.34
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 5.0
Polar Surface Area 38.82
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 28.0

Pharmacology

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Bipolar Disorder 3 D001714 ClinicalTrials
Schizophrenia 3 D012559 ClinicalTrials
Bipolar Disorder 3 D001714 ClinicalTrials
Depressive Disorder, Major 3 D003865 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials
Anxiety Disorders 2 D001008 ClinicalTrials
Child Development Disorders, Pervasive 1 D002659 ClinicalTrials

Related Entries

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 839712-12-8
ChEBI 90933
ChEMBL CHEMBL2028019
DrugBank DB06016
DrugCentral 5037
FDA SRS F6RJL8B278
Guide to Pharmacology 7671
PubChem 11154555
SureChEMBL SCHEMBL184342
ZINC ZINC000100907004